➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Harvard Business School
AstraZeneca
Express Scripts
Merck

Last Updated: August 1, 2021

DrugPatentWatch Database Preview

Details for Patent: 8,859,623


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,859,623
Title:Methods and compositions of stable phenylephrine formulations
Abstract: The invention is directed to methods and compositions of stabilizing phenylephrine formations. The composition has good time-dependent stability at low temperature and has no change in its outward appearance even after having been stored at least 6 months.
Inventor(s): Witham; Patrick H. (Eugene, OR), Machiraju; Sailaja (Beaverton, OR), Bluett; Lauren Mackensie-Clark (Milwaukie, OR)
Assignee: Paragon Bioteck, Inc. (Portland, OR)
Application Number:14/080,771
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,859,623
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 8,859,623

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Paragon Bioteck PHENYLEPHRINE HYDROCHLORIDE phenylephrine hydrochloride SOLUTION/DROPS;OPHTHALMIC 203510-001 Mar 21, 2013 AT RX Yes Yes ⤷  Try it Free ⤷  Try it Free DILATION OF THE PUPIL ⤷  Try it Free
Paragon Bioteck PHENYLEPHRINE HYDROCHLORIDE phenylephrine hydrochloride SOLUTION/DROPS;OPHTHALMIC 203510-002 Mar 21, 2013 AT RX Yes Yes ⤷  Try it Free ⤷  Try it Free DILATION OF THE PUPIL ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,859,623

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2015073696 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Moodys
Merck
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.